Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bionano Genomics Inc
(NQ:
BNGO
)
0.4900
+0.0068 (+1.41%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bionano Genomics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
The 7 Best Stocks to Buy on a Dip in July
July 14, 2022
With the stock market pricing in a recession that likely won't arrive anytime soon, these are some of the best stocks to buy on a dip.
Via
InvestorPlace
3 Stocks That Could Double in 2022
June 08, 2022
With the market shaking off its downturn and the economy strengthening, there are several stocks that could double before the year is out.
Via
InvestorPlace
Looking Into Bionano Genomics's Return On Capital Employed
May 27, 2022
Bionano Genomics (NASDAQ:BNGO) brought in sales totaling $5.70 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 30.52%, resulting in a loss of $29.95 million.
Via
Benzinga
7 Cheap Biotech Stocks to Buy Now
May 19, 2022
These biotech stocks can be speculative, but have the potential to blow up in the next couple of years for good gains.
Via
InvestorPlace
Bionano Genomics's Earnings Outlook
May 04, 2022
Bionano Genomics (NASDAQ:BNGO) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Bionano...
Via
Benzinga
Hold On to Bionano Genomics Stock Until It Reaches $6 at Least
March 08, 2022
After a year of blockbuster revenue growth, BNGO stock deserves a major re-rating
Via
InvestorPlace
Earnings Scheduled For March 1, 2022
March 01, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...
Via
Benzinga
The Latest Studies by Bionano Genomics Are Promising, But It’s Not a Buy Yet
April 11, 2022
BNGO stock has provided positive news from study results lately, but its fundamentals are not great and not a reason to invest in it now.
Via
InvestorPlace
Why Bionano Genomics Stock Is Risky, but a Good Bet
April 01, 2022
The risks may be clear when it comes to Bionano Genomics and BNGO stock. However, investors should see this as a long-term play.
Via
InvestorPlace
Bionano Genomics Stock Can Regain the Crucial $5 Level
March 22, 2022
Bionano Genomics is working hard to address rare diseases, yet Wall Street doesn't see the value in BNGO stock -- but that could change soon.
Via
InvestorPlace
Bionano Genomics May Finally Offer a Reward for Your Risk
March 18, 2022
BNGO stock has been a falling knife for the past year. But, with promising fundamentals and good tailwinds, now be the time to take a chance.
Via
InvestorPlace
Bionano Genomics's Return On Capital Employed Insights
March 04, 2022
Benzinga Pro data, Bionano Genomics (NASDAQ:BNGO) reported Q4 sales of $6.30 million. Earnings fell to a loss of $22.95 million, resulting in a 10.58% decrease from last quarter...
Via
Benzinga
Bionano Genomics's Earnings Outlook
February 28, 2022
Bionano Genomics (NASDAQ:BNGO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Bionano Genomics Has Attractive Applications But An Unattractive Stock Price
February 24, 2022
BNGO stock will witness more hard times until profitability is improved and sales start to rebound. That could take some time.
Via
InvestorPlace
Bionano Stock Looks to Have a Monster Comeback in Its Future
February 17, 2022
Bionano's Saphyr appears to be able to help doctors treat leukemia, and the adoption of its device is growing rapidly.
Via
InvestorPlace
Investors Have Cast Their ‘No’ Votes Against Bionano Genomics
February 07, 2022
A preliminary report from Bionano Genomics doesn't tell the full story and a lack of profitability will likely weigh on BNGO stock.
Via
InvestorPlace
Bionano Is Not the Genomics Stock To Bet On
February 04, 2022
Bionano's recent results are lackluster and point to more volatility ahead for BNGO stock. Best to just avoid this stock for now.
Via
InvestorPlace
Bionano Genomics Is Interesting as Genome Testing Scales Upwards
January 25, 2022
BNGO Stock is a play in the burgeoning gene sequencing market at scale, not at home. That's worth understanding and potentially purchasing.
Via
InvestorPlace
Bionano Genomics Preliminary Q4, FY21 Revenue Exceed Expectations
January 12, 2022
Bionano Genomics Inc (NASDAQ: BNGO) posted preliminary Q4 sales of $5.8 million - $6.2 million, +25% - 33% sequentially, up 45% - 55% Y/Y, and above the consensus...
Via
Benzinga
7 of the Best Cheap Stocks Under $10 for 2022 to Buy Now
January 06, 2022
These cheap stocks under $10 are poised to rally in the new, more friendly macro environment that's in place as 2022 unfolds.
Via
InvestorPlace
Bionano Genomics Stock Is a Low-Priced Bet on Sound Science
January 03, 2022
Even though BNGO stock investors struggled in 2021, prepare for new price discovery as Bionano pushes the envelope in optical genome mapping.
Via
InvestorPlace
The Critics Are Wrong About Bionano Stock
December 27, 2021
The critics of Bionano are greatly underestimating the vast potential of Saphyr and of BNGO stock for long-term investors.
Via
InvestorPlace
This Analyst’s Saphyr Calculations Suggest Buying Bionano While It’s Down
December 14, 2021
If BNGO stock reaches Oppenheimer’s price target, investors are looking at a return of more than 300%, plus long-term growth potential.
Via
InvestorPlace
5 Penny Stocks Insiders Are Buying
December 01, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...
Via
Benzinga
Bionano Genomics Proves Not Everything Genetic is Gold
December 01, 2021
Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes.
Via
InvestorPlace
Jim Cramer Shares His Thoughts On Chegg, Bristol-Myers Squibb And More
November 30, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said with Matterport, Inc. (NASDAQ:
Via
Benzinga
Wait for Bionano Stock to Fall Further Before Buying
November 23, 2021
BNGO stock is breaking down following the latest earnings report, and there are no major catalysts to push shares up in the short term.
Via
InvestorPlace
Bionano’s Is on Track for Growth Thanks to Saphyr
November 19, 2021
BNGO stock beats analyst forecasts yet again. Flush with cash and with Saphyr installations rising, this stock remains a high potential play.
Via
InvestorPlace
With Progress on Multiple Fronts, Bionano Genomics Stock Is Great Buy Here
November 12, 2021
Bionano's acquisition of a software company makes Saphyr more attractive, and studies should result in insurers reimbursing those who use the system. BNGO stock is a buy.
Via
InvestorPlace
Bionano Genomics, Inc (BNGO) Q3 2021 Earnings Call Transcript
November 06, 2021
BNGO earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.